Muscle Loss on GLP-1s: What the Research Actually Says

“You lose muscle on these drugs” is one of the most repeated claims about GLP-1s, and it is roughly true. But the number people quote is usually borrowed from the wrong trial, and the thing being measured is usually not what people think it is.

What the trials actually measured

Two of the major trials ran DEXA sub-studies, which scan body composition rather than just weighing people. They found meaningfully different results.

DEXA sub-study	Lean soft tissue lost	Fat mass lost	Lean share of total loss
STEP 1 — semaglutide (n=95)	6.9 kg	10.4 kg	~40%
SURMOUNT-1 — tirzepatide (n=124)	5.6 kg	15.9 kg	~25%

This is the detail most write-ups miss. The widely-quoted “up to 40% of what you lose is lean mass” comes from the semaglutide data. In the tirzepatide sub-study the figure was closer to a quarter, because participants lost considerably more fat while losing slightly less lean tissue.

Two honest caveats. These were small sub-groups inside much larger trials, so the precision implied by a percentage is greater than the evidence supports. And they were separate trials with different populations — not a head-to-head comparison of body composition, so the gap between them is suggestive rather than settled.

What “lean mass” does and doesn’t mean

DEXA reports lean soft tissue, and that is not a synonym for muscle. It includes water, glycogen, connective tissue and the mass of your organs.

That matters because the first weeks of any significant calorie reduction involve losing glycogen and the water bound to it — roughly 3 grams of water per gram of glycogen. Some of what registers as early “lean mass loss” on a scan is that, not contractile muscle disappearing.

It also matters in the other direction: some of it is muscle, and losing muscle has real consequences for strength, metabolic rate and — particularly over 60 — fall risk and independence. The honest summary is that lean-mass loss is real, worth acting on, and smaller than the scariest framings imply.

Is this abnormal, or just what weight loss does?

Mostly the latter, and this is the context that usually gets dropped.

Losing lean tissue alongside fat is a feature of any substantial weight loss — dieting, bariatric surgery, illness. Across those settings the lean share typically lands in a similar 20–40% band. GLP-1 medications are not doing something uniquely destructive to muscle; they are producing rapid weight loss, and rapid weight loss has always cost lean tissue.

What is arguably different is the speed and scale, and that people on these medications often eat far less protein than they intend, because appetite suppression makes protein — the most filling macronutrient — the hardest thing to finish.

The two protective factors with the best evidence

Resistance training. The most consistent finding in the weight-loss literature. Resistance exercise during calorie restriction preserves fat-free mass substantially better than dieting alone, or dieting plus cardio. Two or three sessions a week is the commonly studied pattern — this is not a gym-heavy prescription.

Adequate protein. Higher protein intake during weight loss preserves fat-free mass better than lower intake. Sports-nutrition position stands generally cite ranges around 1.2–2.0 g/kg/day during active weight reduction, though the right number is individual. Our protein target guide explains how those ranges are calculated.

The two together outperform either alone. Neither is exotic, and neither requires a supplement.

What we don’t know yet

Whether the composition difference between the two drugs holds up outside trial conditions is genuinely unsettled — at least one routine-care analysis has pointed the other way, and it has not yet been peer-reviewed, so we are not treating it as established.

We also do not have good long-term data on whether lean tissue is regained after stopping, or how much the protective effect of training changes the picture over several years. Anyone stating those confidently is ahead of the evidence.

Questions worth asking your prescriber

1. Should I have a baseline body-composition measurement before or early in treatment, so changes are measurable rather than guessed at?
2. What protein target makes sense for me — particularly with kidney disease, where the usual ranges may not apply?
3. Is resistance training safe given my other conditions, and how should I start?
4. Are there signs of losing too much lean tissue you would want me to report?

Educational content only. This is not medical or dietary advice, and protein targets in particular need individual input if you have kidney disease, diabetes treated with other medication, or a prescribed diet.